Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury
- 30 September 1991
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 52 (3) , 495-499
- https://doi.org/10.1016/0003-4975(91)90911-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumPublished by Elsevier ,2002
- Neutrophil depletion does not prevent myocardial dysfunction after brief coronary occlusionJournal of the American College of Cardiology, 1989
- Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.Circulation, 1989
- Comparison of single dose versus multiple dose crystalloid cardioplegia in neonateThe Journal of Thoracic and Cardiovascular Surgery, 1989
- Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.Circulation, 1988
- Comparison of vasodilator effects of DN-9693, a selective inhibitor of cyclic AMP phosphodiesterase, and isobutylmethylxanthine, a non-selective one, in dogs.The Japanese Journal of Pharmacology, 1986
- Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusionAmerican Heart Journal, 1986
- Neutrophil Depletion Suppresses 111In-Labeled Platelet Accumulation in Infarcted MyocardiumJournal of Cardiovascular Pharmacology, 1985
- Interactions between prostaglandins and leukotrienesBiochemical Pharmacology, 1984
- Scar thinning due to ibuprofen administration after experimental myocardial infarctionThe American Journal of Cardiology, 1983